NEFL and myeloid sarcoma: In serum, NfL was elevated across all CIS and MS subgroups, GFAP was increased in RRMS and SPMS subgroups, and myelin oligodendrocyte glycoprotein (MOG) was increased in RRMS and PPMS subgroups.